Frazier Life Sciences Management, L.P.
Source: SEC Form 13F · as of Mar 2026Frazier Life Sciences Management, L.P. holds 13 biotech & pharma companies tracked by BioSniper, totaling $808.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$808.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for BridgeBio Pharma, Inc. (BBIO)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| BBIOBridgeBio Pharma, Inc. | 3,448,139 | $256.1M |
| KRYSKrystal Biotech, Inc. | 481,307 | $124.3M |
| CYTKCYTOKINETICS INC | 1,159,879 | $76.4M |
| RVMDREVOLUTION MEDICINES, INC. | 675,686 | $65.7M |
| DYNDyne Therapeutics, Inc. | 3,153,082 | $57.2M |
| TARSTarsus Pharmaceuticals, Inc. | 728,644 | $51.1M |
| AGIOAGIOS PHARMACEUTICALS, INC. | 1,256,080 | $42.5M |
| BCRXBIOCRYST PHARMACEUTICALS INC | 4,009,240 | $38.2M |
| ACADACADIA PHARMACEUTICALS INC | 1,438,198 | $32.0M |
| ALKSAlkermes plc. | 700,647 | $24.8M |
| GLUEMonte Rosa Therapeutics, Inc. | 1,000,000 | $16.4M |
| IMCRImmunocore Holdings plc | 484,782 | $14.6M |
| ALLOAllogene Therapeutics, Inc. | 3,796,668 | $9.3M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.